MISTIE GRANBERRY: Open Payments
NPI 1639587462 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 57 payments from 14 companies in 2025. Trend: 2023 $986 · 2024 $865 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $282 |
| BIOTRONIK INC. | 12 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $121 |
| Medtronic, Inc. | 1 | $120 |
| Novo Nordisk Inc | 4 | $78 |
| SCPHARMACEUTICALS INC. | 4 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $74 |
| Kestra Medical Technology Services, Inc. | 2 | $58 |
| Boston Scientific Corporation | 1 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: CAMZYOS, LEQVIO, COREVALVE EVOLUT R, FUROSCIX, ELIQUIS, LifeVest, BIOMONITOR, Wegovy.
Industry payments across TX — which companies pay providers there.
